86 related articles for article (PubMed ID: 32837192)
1. Paradigm shift of drug information centers during the COVID-19 pandemic.
Khatiwada AP; Shakya S; Shrestha S
Drugs Ther Perspect; 2020; 36(9):389-395. PubMed ID: 32837192
[TBL] [Abstract][Full Text] [Related]
2. Drug Information Services Today: Current Role and Future Perspectives in Rational Drug Therapy.
Amundstuen Reppe L; Spigset O; Schjøtt J
Clin Ther; 2016 Feb; 38(2):414-21. PubMed ID: 26831829
[TBL] [Abstract][Full Text] [Related]
3. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
Zheng SQ; Yang L; Zhou PX; Li HB; Liu F; Zhao RS
Res Social Adm Pharm; 2021 Jan; 17(1):1819-1824. PubMed ID: 32249102
[TBL] [Abstract][Full Text] [Related]
4. Current status of pharmacist-operated drug information centers in the United States.
Rosenberg JM; Koumis T; Nathan JP; Cicero LA; McGuire H
Am J Health Syst Pharm; 2004 Oct; 61(19):2023-32. PubMed ID: 15509125
[TBL] [Abstract][Full Text] [Related]
5. Drug information centers: future trends.
Rosenberg JM
Am J Hosp Pharm; 1983 Jul; 40(7):1213-5. PubMed ID: 6881162
[TBL] [Abstract][Full Text] [Related]
6. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
Aruru M; Truong HA; Clark S
Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
[TBL] [Abstract][Full Text] [Related]
7. Comparing professional and consumer drug information centers.
Russello CM; Peterson AM
Am Pharm; 1993 Nov; NS33(11):49-52. PubMed ID: 8249830
[TBL] [Abstract][Full Text] [Related]
8. Drug information centers: meeting future needs for drug information.
Cardoni AA
Am J Hosp Pharm; 1983 Jul; 40(7):1215-7. PubMed ID: 6881163
[TBL] [Abstract][Full Text] [Related]
9. Patients' Habits and the Role of Pharmacists and Telemedicine as Elements of a Modern Health Care System during the COVID-19 Pandemic.
Grosman-Dziewiszek P; Wiatrak B; Jęśkowiak I; Szeląg A
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575322
[TBL] [Abstract][Full Text] [Related]
10. Pharmacist-operated drug information centres in Singapore.
Lim LY; Chui WK
J Clin Pharm Ther; 1999 Feb; 24(1):33-42. PubMed ID: 10319905
[TBL] [Abstract][Full Text] [Related]
11. The Role of Pharmacists in the Fight Against COVID-19.
Chahine EB
Sr Care Pharm; 2020 Jul; 35(7):286-291. PubMed ID: 32600505
[TBL] [Abstract][Full Text] [Related]
12. [Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?].
El-Hage W; Hingray C; Lemogne C; Yrondi A; Brunault P; Bienvenu T; Etain B; Paquet C; Gohier B; Bennabi D; Birmes P; Sauvaget A; Fakra E; Prieto N; Bulteau S; Vidailhet P; Camus V; Leboyer M; Krebs MO; Aouizerate B
Encephale; 2020 Jun; 46(3S):S73-S80. PubMed ID: 32370984
[TBL] [Abstract][Full Text] [Related]
13. European drug information centres--survey of activities.
Müllerová H; Vlcek J
Pharm World Sci; 1998 Jun; 20(3):131-5. PubMed ID: 9618737
[TBL] [Abstract][Full Text] [Related]
14. Update on the status of 89 drug information centers in the United States.
Rosenberg JM; Schilit S; Nathan JP; Zerilli T; McGuire H
Am J Health Syst Pharm; 2009 Oct; 66(19):1718-22. PubMed ID: 19767377
[TBL] [Abstract][Full Text] [Related]
15. Survey of drug information centers in the United States-2018.
Grossman S; Nathan JP; Ipema HJ; Ness GL; Tierno HE; Gabay MP; Calip GS
Am J Health Syst Pharm; 2020 Jan; 77(1):33-38. PubMed ID: 31743390
[TBL] [Abstract][Full Text] [Related]
16. National audit of drug information centers.
Dombrowski SR; Visconti JA
Am J Hosp Pharm; 1985 Apr; 42(4):819-26. PubMed ID: 4014232
[TBL] [Abstract][Full Text] [Related]
17. Pharmacist-operated drug information centers in the United States--1986.
Rosenberg JM; Martino FP; Kirschenbaum HL; Robbins J
Am J Hosp Pharm; 1987 Feb; 44(2):337-44. PubMed ID: 3565393
[TBL] [Abstract][Full Text] [Related]
18. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
[TBL] [Abstract][Full Text] [Related]
19. Pharmacists' Preparedness to Patients Education at the Time of Pandemic-A Cross-Sectional Study with an Example of SARS-CoV-2 Outbreak in Poland.
Cerbin-Koczorowska M; Waszyk-Nowaczyk M; Przymuszała P
Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32932684
[TBL] [Abstract][Full Text] [Related]
20. Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries.
Paudyal V; Cadogan C; Fialová D; Henman MC; Hazen A; Okuyan B; Lutters M; Stewart D
Res Social Adm Pharm; 2021 Aug; 17(8):1507-1517. PubMed ID: 33288420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
